Literature DB >> 17989733

Critical review of generic and dermatology-specific health-related quality of life instruments.

Hilde Both1, Marie-Louise Essink-Bot, Jan Busschbach, Tamar Nijsten.   

Abstract

The measurement of health-related quality of life (HRQOL) is increasingly important in patients with skin diseases. Despite the availability of a variety of instruments and new psychometric techniques, there is no consensus as to which HRQOL instruments are to be preferred in dermatology. The objective of this review is to evaluate the generic HRQOL measures (i.e., health profiles) that have been used in dermatology (Short-Form-36 (SF-36) and -12, NHP, SIP, World Health Organization Quality of Life (WHOQOL)-100 and -BREF) and all dermatology-specific HRQOL measures (Dermatology Life Questionnaire Index, Skindex-29, -16, and -17, Dermatology Quality of Life Scales, and Dermatology-Specific Quality of Life). Criteria for evaluation were adapted from existing guidelines and included conceptual and measurement model, reliability, validity, responsiveness, item functioning, meaning of scores, administrative burden, respondent burden, the availability of alternative forms, and of cultural and language adaptations. Furthermore, an overview of skin diseases in which the included HRQOL tools have been used is presented. Although the selection of the appropriate HRQOL instrument remains a trade-off between various psychometric properties and research objectives, for now, we recommend the combination of SF-36 and Skindex-29 as the instruments of choice in dermatology. Promising new instruments for future research are the WHOQOL and the Skindex-17.

Entities:  

Mesh:

Year:  2007        PMID: 17989733     DOI: 10.1038/sj.jid.5701142

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  58 in total

1.  The botulinum toxin experience: results of a patient self-report questionnaire.

Authors:  Richard G Fried; Wm Philip Werschler; Tracy Floirendo
Journal:  J Clin Aesthet Dermatol       Date:  2009-11

2.  Assessment of the Dermatology Life Quality Index (DLQI) in a homogeneous population under lifetime arsenic exposure.

Authors:  Yi Xiao; Xiaoyan Huang; Danrong Jing; Yuzhou Huang; Xingyu Zhang; Zhihao Shu; Zhijun Huang; Juan Su; Jie Li; Jianglin Zhang; Mingliang Chen; Xiang Chen; Minxue Shen
Journal:  Qual Life Res       Date:  2018-09-10       Impact factor: 4.147

3.  Children and adolescents' health-related quality of life in relation to eczema, asthma and hay fever: results from a population-based cross-sectional study.

Authors:  Uwe Matterne; Jochen Schmitt; Thomas L Diepgen; Christian Apfelbacher
Journal:  Qual Life Res       Date:  2011-02-24       Impact factor: 4.147

4.  Interpretation of quality-of-life scores.

Authors:  Mary-Margaret Chren
Journal:  J Invest Dermatol       Date:  2010-05       Impact factor: 8.551

5.  Quality of life in colon cancer patients with skin side effects: preliminary results from a monocentric cross sectional study.

Authors:  Federica Andreis; Anna Rizzi; Paola Mosconi; Claudia Braun; Luigina Rota; Fausto Meriggi; Maria Mazzocchi; Alberto Zaniboni
Journal:  Health Qual Life Outcomes       Date:  2010-04-15       Impact factor: 3.186

Review 6.  Quality of life in patients with bullous dermatoses.

Authors:  Deshan F Sebaratnam; James R McMillan; Victoria P Werth; Dédée F Murrell
Journal:  Clin Dermatol       Date:  2012 Jan-Feb       Impact factor: 3.541

7.  Reliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasis.

Authors:  E D Dommasch; D B Shin; A B Troxel; D J Margolis; J M Gelfand
Journal:  Br J Dermatol       Date:  2009-11-10       Impact factor: 9.302

8.  Validity and Reliability of the Dutch Adaptation of the Actinic Keratosis Quality of Life Questionnaire (AKQoL).

Authors:  Kelly Vis; Rick Waalboer-Spuij; Dyon G C T M Snels; Loes M Hollestein
Journal:  Dermatology       Date:  2018-06-15       Impact factor: 5.366

9.  Effect of store and forward teledermatology on quality of life: a randomized controlled trial.

Authors:  John D Whited; Erin M Warshaw; Karen E Edison; Kush Kapur; Lizy Thottapurathu; Srihari Raju; Bethany Cook; Holly Engasser; Samantha Pullen; Patricia Parks; Tom Sindowski; Danuta Motyka; Rodney Brown; Thomas E Moritz; Santanu K Datta; Mary-Margaret Chren; Lucinda Marty; Domenic J Reda
Journal:  JAMA Dermatol       Date:  2013-05       Impact factor: 10.282

Review 10.  A systematic review of health-related quality of life in cutaneous melanoma.

Authors:  D Cornish; C Holterhues; L V van de Poll-Franse; J W Coebergh; T Nijsten
Journal:  Ann Oncol       Date:  2009-08       Impact factor: 32.976

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.